In this editorial from Bioanalysis, a collection of experts from CROs across the globe provide a CRO perspective on the potential impact of the ICH M10 guidance.
The US FDA has granted emergency use authorization for coronavirus assays from Hologic (MA, USA) and Labcorp (NC, USA). The assays will join those provided by Roche (Basel, Switzerland) and Thermo Fisher Scientific (MA, USA).
This infographic highlights the key qualities to look for in a CRO to ensure the best results when outsourcing immunogenicity assay development and testing.
This presentation from SCIEX (Warrington, UK) explores why we need high-resolution accurate mass spectrometry quantification, discussing topics ranging from the desire for higher selectivity in complex matrices to the need to analyze multiple charge states and fragment ions.
Webinar available to view on demand. Exploring the challenges a lack of industry standardization presents for CRO project managers and scientists as well as biopharma and biotech companies.
What does the future hold for relationships between pharma and CRO? Find out what our experts think in this ‘Ask the Experts’ interview.
How may different factors affect outsourcing? Find out from our experts representing CROs and pharma.
Find out more about the challenges associated with outsourcing in this comparative piece for our ‘Ask the Experts’ feature on outsourcing.
What is important when selecting an organization for outsourcing work? Find out from our experts representing CRO and pharma backgrounds in this Ask the Experts feature.
Hear from our experts about what areas they send or recieve outsourced work from, including respresentatives from CRO and pharma perspectives.